Reuters: Health
The U.S. Food and Drug Administration on Monday declined to approve Lipocine Inc's oral drug to treat a condition that results in lower production of sex hormone, the third regulatory setback for the drug in over three years.
FDA declines to approve Lipocine's testosterone drug for third time
FDA declines to approve Lipocine's testosterone drug for third time
Reuters: Health
The U.S. Food and Drug Administration on Monday declined to approve Lipocine Inc's oral drug to treat a condition that results in lower production of sex hormone, the third regulatory setback for the drug in over three years.
Reuters: Health
The U.S. Food and Drug Administration on Monday declined to approve Lipocine Inc's oral drug to treat a condition that results in lower production of sex hormone, the third regulatory setback for the drug in over three years.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment